BL
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
1.094
Exchange
XNAS - Nasdaq
0.0065 B
Last period CFO ,USD
9327%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also BioLife
Company Analysis
BLFS valuation, rating, competitors, insights and company profile
Eyestock Rating
BLFS financial analysis by Eyestock methodology
Valuation
BLFS valuation using historical relative method
Statements
BLFS Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BLFS dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
BioLife`s CFO for the period ended 2024-06-30 is 0.0065 B USD
